Cargando…

Prescribing trend of tapentadol in a Sydney local health district

AIMS: Tapentadol, an opioid with mu‐opioid receptor agonism and noradrenaline reuptake inhibition, has been increasingly used in Australia since 2011. However, data on hospital prescribing trends and indications are scarce. This study aimed to investigate hospital prescribing trends of tapentadol, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirabella, Jennifer, Ravi, Deepa, Chiew, Angela L., Buckley, Nicholas A., Chan, Betty S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544395/ https://www.ncbi.nlm.nih.gov/pubmed/35763675 http://dx.doi.org/10.1111/bcp.15448

Ejemplares similares

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

Northern Sydney Local Health District (NSLHD) eating disorders project
por: Wildman, Rochelle, et al.
Publicado: (2014)

Sydney Local Health District’s Integrated Response to the COVID-19 Pandemic: A Descriptive Study
por: Liu, Darith, et al.
Publicado: (2022)

Tapentadol and Oxycodone/Naloxone Prescribing Patterns in Primary Health Care in Catalonia, Spain: A Cross-Sectional Study
por: Viñas-Bastart, Montserrat, et al.
Publicado: (2021)

Audit of high dose antipsychotics (HDA) prescribing on high dependency unit (HDU) and acute ward, Nepean Mental Health Centre, Nepean Blue Mountains Local Health District, Sydney, Australia
por: Jawad, Adil, et al.
Publicado: (2021)

Tapentadol: an overview of the safety profile
por: Polati, Enrico, et al.
Publicado: (2019)

Towards an effective collaboration between the South Western Sydney Local Health District and local councils: insights from a qualitative study
por: Kovai, Vilas, et al.
Publicado: (2022)

Care Coordination for Vulnerable Families in the Sydney Local Health District: What Works for Whom, under What Circumstances, and Why?
por: Eastwood, John G., et al.
Publicado: (2020)

Assessment of Health Research Capacity in Western Sydney Local Health District (WSLHD): A Study on Medical, Nursing and Allied Health Professionals
por: Lee, Sharon A, et al.
Publicado: (2020)

Audit of the Sydney Local Health District Public Health Unit notification and contact tracing system during the first wave of COVID‐19
por: Jain, Naveena, et al.
Publicado: (2021)

Tapentadol hydrochloride: A novel analgesic
por: Singh, Dewan Roshan, et al.
Publicado: (2013)

Outcomes of the Pediatric Development Plan of Tapentadol
por: Eerdekens, Mariëlle, et al.
Publicado: (2021)

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018)

Variability of Oxaliplatin-Induced Neuropathic Pain Symptoms in Each Cycle and Its Implications on the Management of Colorectal Cancer Patients: A Retrospective Study in South Western Sydney Local Health District Hospitals, Sydney, Australia
por: Gebremedhn, Endale G., et al.
Publicado: (2019)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Verification and implementation of a rapid antigen test for SARS-CoV2 detection in clinical settings in Sydney local health district (SLHD)
por: Mathew, Susy, et al.
Publicado: (2022)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
por: Otto, Jan C., et al.
Publicado: (2019)

Understanding for whom, how and why Sydney Local Health District’s Integrated Response was Effective in Addressing COVID-19: A Critical Realist Qualitative Study
por: Liu, Hueiming, et al.
Publicado: (2022)

Prediction of response to tapentadol in chronic low back pain
por: Reimer, M., et al.
Publicado: (2016)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Comparison of tapentadol with tramadol for analgesia after cardiac surgery
por: Iyer, Srinivas Kalyanaraman, et al.
Publicado: (2015)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence
por: Rinonapoli, Giuseppe, et al.
Publicado: (2019)

Tapentadol, the new kid on the block in India: Is it time to worry?
por: Basu, Debasish, et al.
Publicado: (2020)

Sydney Selwyn
por: Price, Robin
Publicado: (1997)

Plague at Sydney
Publicado: (1904)

Sydney Chung
Publicado: (2017)

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study
por: Vosburg, Suzanne K, et al.
Publicado: (2022)

Diversion and Illicit Sale of Extended Release Tapentadol in the United States
por: Dart, Richard C., et al.
Publicado: (2016)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
por: Sansone, Pasquale, et al.
Publicado: (2022)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

Application of Design of Experiment for Floating Drug Delivery of Tapentadol Hydrochloride
por: Jagdale, Swati C., et al.
Publicado: (2013)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Is tapentadol a potential Trojan horse in the postdextropropoxyphene era in India?
por: Basu, Aniruddha, et al.
Publicado: (2018)

Correction to: Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2019)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Pharmacological rationale for tapentadol therapy: a review of new evidence
por: Romualdi, Patrizia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m6kdlkpiohc5jelch9m9jrdu5d